Combination immunotherapy of chlorogenic acid liposomes modified with sialic acid and PD-1 blockers effectively enhances the anti-tumor immune response and therapeutic effects

• Главные авторы: Xixi Li (Автор), Shunyao Zhu (Автор), Ping Yin (Автор), Shuangshuang Zhang (Автор), Juewen Xu (Автор), Qin Zhang (Автор), Senlin Shi (Автор), Ting Zhang (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Melanoma is one of the most common malignant tumors. The anti-PD-1 antibody is used for the treatment of metastatic melanoma. Treatment success is only 35-40% and a range of immune-related adverse reactions can occur. Combination of anti-PD1 antibody therapy with other oncology therapies has been at...